Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | NQO2 | P16083 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | BCR | P11274 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16909647 | 0.90 | CA1 (0.46) | CYP1A2CYP2A6KDM4ERAB9AALDH1A1 | |
| SCHEMBL3874584 | 0.89 | GPR3 (0.49) | CYP1A2CYP2A6GPR3KDM4ERAB9A | |
| SCHEMBL20553766 | 0.86 | ABL1 (0.50) | RAB9ASMN1; SMN2NPC1ABL1ABCB1 | |
| SCHEMBL20553770 | 0.83 | LTA4H (0.56) | KDM4ERAB9AALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL20553960 | 0.81 | LTA4H (0.46) | GAA | |
| SCHEMBL3879642 | 0.80 | PDK2 (0.42) | RAB9AALDH1A1SMN1; SMN2NPC1MEN1 | |
| SCHEMBL3870558 | 0.80 | L3MBTL1 (0.47) | KDM4ERAB9AALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL29086531 | 0.80 | ALDH1A1 (0.51) | KDM4ERAB9AALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL3869162 | 0.78 | LTA4H (0.46) | CYP1A2RAB9AALDH1A1NPC1MEN1 | |
| SCHEMBL29086596 | 0.77 | KMT2A (0.50) | RAB9ASMN1; SMN2NPC1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2657315-B1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2020-12-16 | — | — | EP | disclosed |
| US-9349964-B2 | Organic light emitting diode and manufacturing method thereof | LG CHEM, LTD. (KR) | 2016-05-24 | — | — | US | disclosed |
| EP-2657315-A2 | ORGANIC LIGHT-EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | LG Chem, Ltd. (KR) | 2013-10-30 | — | — | EP | disclosed |
| US-20120193612-A1 | ORGANIC LIGHT EMITTING DIODE AND MANUFACTURING METHOD THEREOF | LG CHEM, LTD. (KR) | 2012-08-02 | — | — | US | disclosed |
| US-7482490-B2 | Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound | TOSOH CORPORATION (JP) | 2009-01-27 | — | — | US | disclosed |
| US-20080194878-A1 | Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound | TOSOH CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-7189877-B2 | Arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | TOSCH CORPORATION (JP) | 2007-03-13 | — | — | US | disclosed |
| EP-1752440-A1 | AMINE COMPOUND HAVING FLUORENE GROUP AS FRAMEWORK, PROCESS FOR PRODUCING THE AMINE COMPOUND, AND USE OF THE AMINE COMPOUND | Tosoh Corporation (JP) | 2007-02-14 | — | — | EP | disclosed |
| EP-1400578-B1 | Electrolumisescent 9,9-bis(4-amino)-1,1'-biphenyl)fluorene derivatives | TOSOH CORP (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-6824939-B2 | PHOTORECEPTOR INCLUDING A PROTECTIVE LAYER INCLUDING A FILLER; PRODUCE HIGH QUALITY IMAGES FOR A LONG PERIOD OF TIME WITHOUT CAUSING DETERIORATION OF THE IMAGE RESOLUTION DUE TO SCATTERING OR DIFFUSE REFLECTION OF THE LASER LIGHT | RICOH COMPANY LIMITED (JP) | 2004-11-30 | — | — | US | disclosed |
| JP-2004315495-A | NEW ARYLAMINE DERIVATIVE HAVING FLUORENE SKELETON, SYNTHETIC INTERMEDIATE OF THE SAME, METHOD FOR PRODUCING THEM AND ORGANIC EL ELEMENT | TOSOH CORP | 2004-11-11 | — | — | JP | disclosed |
| US-20040110958-A1 | Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | TOSOH CORPORATION | 2004-06-10 | — | — | US | disclosed |
| EP-1400578-A1 | Electrolumisescent 9,9-bis(4-amino)-1,1'-biphenyl)fluorene derivatives | Tosoh Corporation (JP) | 2004-03-24 | — | — | EP | disclosed |
| US-20030206226-A1 | Electrophotographic image forming method and apparatus | RICOH COMPANY LIMITED (JP) | 2003-11-06 | — | — | US | disclosed |
| US-5364739-A | Photocrosslinking, thermochromism | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-11-15 | — | — | US | disclosed |
| US-RE32162-E | Pressure sensitive record material employing diaryl alkane solvents | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1986-05-27 | — | — | US | disclosed |
| US-4289806-A | DYE DISSOLVED IN SOLVENT OF AROMATIC HYDROCARBONS HAVING TWO OR THREE NON-CONDENSED BENZENE RINGS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1981-09-15 | — | — | US | disclosed |
| US-4148968-A | COLORLESS TONER, A POLYMER OR CLAY AND A FATTY ACID OR DERIVATIVE | CANON KABUSHIKI KAISHA (JP) | 1979-04-10 | — | — | US | disclosed |
| US-4054712-A | ELECTROGRAPHY | CANON KABUSHIKI KAISHA (JA) | 1977-10-18 | — | — | US | disclosed |
| US-3936566-A | Pressure sensitive record material employing diaryl alkane solvents | NIPPON PETROCHEMICALS COMPANY LTD. (JA) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110958-A1 | Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | AHR, NAT1, AR | CYP1A2 22/4885CYP2A6 257/4885GPR3 370/4885 |
| US-20080194878-A1 | Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound | TAAR1, SLC18A1, ADRB2 | CYP1A2 312/4885CYP2A6 1015/4885GPR3 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.